Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients

World J Gastroenterol. 2023 Jul 14;29(26):4099-4119. doi: 10.3748/wjg.v29.i26.4099.

Abstract

Coronavirus disease 2019 (COVID-19) has several extrapulmonary symptoms. Gastrointestinal (GI) symptoms are among the most frequent clinical manifestations of COVID-19, with severe consequences reported in elderly patients. Furthermore, the impact of COVID-19 on patients with pre-existing digestive diseases still needs to be fully elucidated, particularly in the older population. This review aimed to investigate the impact of COVID-19 on the GI tract, liver, and pancreas in individuals with and without previous digestive diseases, with a particular focus on the elderly, highlighting the distinctive characteristics observed in this population. Finally, the effectiveness and adverse events of the anti-COVID-19 vaccination in patients with digestive disorders and the peculiarities found in the elderly are discussed.

Keywords: COVID-19; Cirrhosis; Elderly; Inflammatory bowel disease; Liver disease; Pancreatic disease.

Publication types

  • Review

MeSH terms

  • Aged
  • COVID-19* / complications
  • Gastrointestinal Diseases* / diagnosis
  • Humans
  • Liver
  • SARS-CoV-2